Press release – Medexprim joins the first class of PariSanté Campus

Medexprim has joined the first class of the scientific interest group PariSanté Campus, composed of 60 startups representing the best of digital health in France, to stimulate the exploitation of health data for research, innovation, and care.

PariSanté Campus is part of the government’s overall strategy “to strengthen the resources dedicated to research and innovation in digital health and to build a special partnership with the world of healthcare, particularly university hospitals initiatives,” says Frédérique Vidal, Minister of Higher Education, Research and Innovation

According to Professor Antoine Tesnière, Director General of PariSanté Campus, its ambition is to “bring together the best expertise to create synergies and accelerate the digital transformation of our healthcare system, with the aim of achieving concrete improvements for our fellow citizens.” The 60 startups, from the sectors of artificial intelligence, imaging, medical devices, and digital modeling, “will benefit from exceptional support, which is in line with a completely new State policy on digital health,” adds Professor Tesnière.

Medexprim, representing the “clinical trials” category within PariSanté Campus, aims to improve patient profiling for precision medicine. Romain Cazavan, CEO of Medexprim: “Our goal is to provide researchers with the tools to solve the holistic equation “one patient – one pathology – one treatment”, and to create a network of European partners. We are pleased to see the emergence of such initiatives highlighting the French healthcare innovation ecosystem. We are proud to be part of the first generation and look forward to collaborating with public and private players and to growing Medexprim in France and in Europe. We look forward to being a driving force behind the groundbreaking partnership initiated by PariSanté Campus, @Hôtel-Dieu and Future4care.

French version of the PR

About Medexprim:

Medexprim is Europe’s leading provider of secure imaging and clinical data extraction to accelerate medical research. As a real-world data specialist, we build bridges between leading academic hospitals and pharmaceutical, AI and medical device companies. In compliance with the GDPR, we help hospitals drive their own clinical research strategy and extract value from their data, through our software and services designed with and for clinicians. We provide our partners with secure access to regulatory-grade data. Medexprim aims to build multicentric disease-specific data lakes to serve oncology, neurology and cardiology. We help solve the “one patient, one disease, one treatment” equation to develop precision medicine for better care.

Website: www.medexprim.com
LinkedIn: linkedin.com/company/medexprim

Press contact: Anne-Sophie Labeta – aslabeta@medexprim.com